Keyphrases
Neuroendocrine Tumor
100%
Metastasectomy
100%
Multiple Endocrine Neoplasia Type 1 (MEN1)
100%
Hazard Ratio
71%
Resection
28%
Disease-free Interval
28%
Confidence Interval
28%
R0 Resection
28%
Synchronous Metastases
28%
Improved Survival
14%
Tumor
14%
Recurrence Rate
14%
Overall Survival
14%
Metastasis
14%
Recurrent Disease
14%
10-year Survival
14%
Recurring
14%
Tertiary Care Hospital
14%
Metastasis Sites
14%
Metachronous
14%
Neuroendocrine Dysfunction
14%
Metachronous Disease
14%
Non-functioning Tumor
14%
Medicine and Dentistry
Neuroendocrine Tumor
100%
Metastasectomy
100%
Multiple Endocrine Neoplasia Type I
100%
Hazard Ratio
71%
Metastatic Carcinoma
57%
Diseases
42%
Neoplasm
28%
Recurrent Disease
28%
Overall Survival
14%
Recurrence Risk
14%
Tertiary Care
14%
Predictive Factor
14%
Neuroendocrine Disease
14%